Open Access

Transparent Process

Ret inhibition decreases growth and metastatic potential of estrogen receptor positive breast cancer cells

Albana Gattelli, Ivan Nalvarte, Anne Boulay, Tim C. Roloff, Martin Schreiber, Neil Carragher, Kenneth K. Macleod, Michaela Schlederer, Susanne Lienhard, Lukas Kenner, Maria I. Torres‐Arzayus, Nancy E. Hynes

Author Affiliations

  1. Albana Gattelli1,
  2. Ivan Nalvarte1,
  3. Anne Boulay18,
  4. Tim C. Roloff1,
  5. Martin Schreiber2,
  6. Neil Carragher3,
  7. Kenneth K. Macleod3,
  8. Michaela Schlederer4,
  9. Susanne Lienhard1,
  10. Lukas Kenner4,5,
  11. Maria I. Torres‐Arzayus6 and
  12. Nancy E. Hynes*,1,7
  1. 1Friedrich Miescher Institute for Biomedical Research (FMI), Basel, Switzerland
  2. 2Department of Obstetrics and Gynecology and Comprehensive Cancer Center (CCC), Medical University of Vienna, Vienna, Austria
  3. 3Edinburgh Cancer Research UK Centre, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK
  4. 4Ludwig Boltzmann Institute for Cancer Research (LBI‐CR), Vienna, Austria
  5. 5Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria
  6. 6Division of Molecular and Cellular Oncology, Department of Medical Oncology, Dana‐Farber Cancer Institute and Harvard Medical School, Boston, MA, USA
  7. 7University Basel, Basel, Switzerland
  8. 8Cardiovascular and Metabolic DTA, F.Hoffmann‐La Roche Ltd, Basel, Switzerland
  1. * Corresponding author:
    Tel: +41 61 697 8107; Fax: +41 61 697 3976;
    E‐mail: nancy.hynes{at}
View Abstract

You do not have access to the full text of this article, the first page of the PDF of this article appears below.

PDF extract preview